Balancing efficacy and financial toxicity in the management of metastatic castration-sensitive prostate cancer

被引：0
|
作者：
Sridhar, Srikala S. [1 ]
机构：
[1] Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL | 2019年 / 13卷 / 12期
关键词：
THERAPY;
D O I：
10.5489/cuaj.6346
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：404 / 405
页数：2
相关论文
共 50 条
  • [21] Apalutamide (APA) efficacy and safety in Asian patients with metastatic castration-sensitive prostate cancer (mCSPC)
    Chung, B. H.
    Huang, J.
    Uemura, H.
    Choi, Y. D.
    Ye, Z.
    Suzuki, H.
    Kang, T. W.
    He, D.
    Joung, J. Y.
    Brookman-May, S. D.
    McCarthy, S.
    Bhaumik, A.
    He, J.
    Mundle, S. D.
    Chowdhury, S.
    Agarwal, N.
    Ye, D.
    Chi, K. N.
    Uemura, H.
    ANNALS OF ONCOLOGY, 2021, 32 : S649 - S650
  • [22] Re: Abiraterone plus Prednisone in Metastatic, Castration-Sensitive Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2018, 199 (01): : 26 - 28
  • [23] First-line Therapy for Metastatic Castration-sensitive Prostate Cancer
    Lau, Y. H.
    Wan, L. Y.
    Lam, M. H. C.
    HONG KONG JOURNAL OF RADIOLOGY, 2022, 25 (03): : 244 - 245
  • [24] A TITAN step forward: apalutamide for metastatic castration-sensitive prostate cancer
    Kwon, Daniel Hyuck-Min
    Friedlander, Terence
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7
  • [25] The cost impact of disease progression to metastatic castration-sensitive prostate cancer
    Quoc-Dien Trinh
    Chaves, Leonardo Passos
    Feng, Qi
    Zhu, Julia
    Sandin, Rickard
    Abbott, Thomas
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2022, 28 (05): : 544 - 554
  • [26] Review of Radium-223 and Metastatic Castration-Sensitive Prostate Cancer
    Dandapani, Savita V.
    Wong, Jeffrey
    Twardowski, Przemyslaw
    CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2020, 35 (07) : 490 - 496
  • [27] Current Systemic Therapy in Men with Metastatic Castration-Sensitive Prostate Cancer
    Grisay, Guillaume
    Lavaud, Pernelle
    Fizazi, Karim
    CURRENT ONCOLOGY REPORTS, 2024, 26 (05) : 488 - 495
  • [28] Prognostic Significance of Time to Castration Resistance in Patients With Metastatic Castration-sensitive Prostate Cancer
    Miyake, Hideaki
    Matsushita, Yuto
    Watanabe, Hiromitsu
    Tamura, Keita
    Motoyama, Daisuke
    Ito, Toshiki
    Sugiyama, Takayuki
    Otsuka, Atsushi
    ANTICANCER RESEARCH, 2019, 39 (03) : 1391 - 1396
  • [29] Re: Abiraterone plus Prednisone in Metastatic, Castration-sensitive Prostate Cancer
    Faiena, Izak
    Salmasi, Amirali
    Pantuck, Allan J.
    Drakaki, Alexandra
    EUROPEAN UROLOGY, 2018, 73 (06) : 981 - 981
  • [30] Commentary on: Abiraterone Plus Prednisolone in Metastatic, Castration-sensitive Prostate Cancer
    Struss, Werner J.
    Black, Peter C.
    UROLOGY, 2017, 109 : 1 - 2
12345